Your browser doesn't support javascript.
loading
HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet Pathway to Prevention participants.
Felton, Jamie L; Cuthbertson, David; Warnock, Megan; Lohano, Kuldeep; Meah, Farah; Wentworth, John M; Sosenko, Jay; Evans-Molina, Carmella.
Affiliation
  • Felton JL; Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Cuthbertson D; Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Warnock M; Health Informatics Institute, University of South Florida, Tampa, FL, USA.
  • Lohano K; Health Informatics Institute, University of South Florida, Tampa, FL, USA.
  • Meah F; Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Wentworth JM; Hines VA Medical Center, Hines, IL, USA.
  • Sosenko J; Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Evans-Molina C; Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Parkville, VIC, Australia.
Diabetologia ; 65(1): 88-100, 2022 01.
Article in En | MEDLINE | ID: mdl-34642772

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin Resistance / Diabetes Mellitus, Type 1 / Diabetes Mellitus, Type 2 Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Humans Language: En Journal: Diabetologia Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin Resistance / Diabetes Mellitus, Type 1 / Diabetes Mellitus, Type 2 Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Humans Language: En Journal: Diabetologia Year: 2022 Document type: Article Affiliation country: Country of publication: